Anders Fink-Jensen
Clinical Professor
1 - 3 out of 3Page size: 25
- 2024
- Published
Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis
Kushner, R. F., Fink-Jensen, Anders, Frenkel, O., McGowan, B., Goldman, B., Overvad, M. & Wadden, T., 2024, In: Obesity. 32, 2, p. 273-280 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- E-pub ahead of print
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study
Sass, M. R., Christensen, A. M. B., Christensen, M. L., Gruber, E., Nerdrum, H., Pedersen, L. M., Resch, M., Jørgensen, T. H., Ekstrøm, Claus Thorn, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2024, (E-pub ahead of print) In: Acta Psychiatrica Scandinavica.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Virtual reality-assisted cognitive behavioral therapy for patients with alcohol use disorder: a randomized feasibility study
Thaysen-Petersen, D., Hammerum, S. K., Vissing, A., Oestrich, I. H., Nordentoft, Merete, Düring, S. W. & Fink-Jensen, Anders, 2024, In: Frontiers in Psychiatry. 15, 12 p., 1337898.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 916366
Most downloads
-
5781
downloads
Increased systemic oxidatively generated DNA and RNA damage in schizophrenia
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
223
downloads
Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
158
downloads
Psychiatric disease as a risk factor in fast-track hip and knee replacement: An overview of the literature
Research output: Contribution to journal › Review › Research › peer-review
Published